Eleonora Teplinsky, MD

Eleonora Teplinsky, MD Breast and gynecologic medical oncologist in NJ focusing on patient education and cancer advocacy.
(1)

01/30/2026

Answering two questions about vaginal DHEA:
1. Vaginal DHEA vs vaginal estrogen? One is not necessarily better than the other, and everyone responds differently.
2. Can you use both together? Yes.
More in the video!

01/29/2026

Let’s talk about (Intrarosa) in patients with for genitourinary syndrome of menopause.

DHEA is produced primarily by the adrenal gland and serves as a precursor to estrogen and androgen production. When administered vaginally, it is converted into active forms of estrogen and/or testosterone on intracellular receptors and leads to improvement in vaginal atrophy. Studies have shown that it doesn’t lead to any meaningful increase in serum (blood) hormone concentrations.

The data for using vaginal DHEA in breast cancer mainly comes from the NCCTG N10C1 Alliance study:
• 464 women randomized to receive DHEA 3.25 mg, DHEA 6.5 mg or plain moisturizer nightly for 12 weeks
• All groups (included the moisturizer group) reported improvement in either dryness or painful s*x at 12 weeks
• Improved vaginal cytology with DHEA and greater pH reduction in DHEA arms- signifying improvement in vaginal atrophy
• Women on 6.5 mg DHEA arm did report significantly better s*xual health on female s*xual function index (FSFI) questionnaire.
(6.5 mg is the dose we use!)
• DHEA did result in increased hormone concentrations but in the lowest half or quartile of postmenopausal range and not clinically significant.
• At 12 weeks, there were no significant increases in either estradiol or estrone concentrations among women taking AIs compared to the moisturizer.

We do use vaginal DHEA (prasterone which is a synthetic form - Intrarosa is the brand name) in our patients w breast cancer and this adds to the data supporting the use of vaginal hormones!

Have you used Intrarosa? Share your experiences and questions regarding vaginal hormones!

References: Barton D et al. Support Care Cancer 2018; Labrie F et al. J Steroid Biochem & Mol Biol. 2013.

Comment DHEA and I’ll send you all the links to the references!!

01/24/2026

Loss of muscle mass (sarcopenia) is common after a cancer diagnosis and treatment. Sharing some tips on this topic and let me know your questions and what has worked for you!

01/23/2026

Sharing some tips on aromatase inhibitor associated musculoskeletal syndrome (and joint pain from other cancer therapies as well). I know it can feel like a vicious cycle when it is too painful to exercise!! Share what has worked for you as well.

Here are possible solutions and strategies that can help especially when it is too painful to exercise:
• Medication adjustments: A short break from the aromatase inhibitor or switching aromatase inhibitors (or switching to tamoxifen) might help.
• Over-the-counter pain relief: Short-term use of NSAIDs or acetaminophen is reasonable, but long-term use and opioids are generally discouraged.
• Bone-directed therapies: Bisphosphonates may modestly reduce pain in addition to their benefits for bone health and breast cancer recurrence risk.
• Other medications: Duloxetine is an antidepressant medication that can also be used for chemotherapy-induced peripheral neuropathy and has been shown to have some benefit for joint pain from AIs. Steroids may help but should be limited to short courses due to risks with chronic use.
• Supplements: Some studies show potential benefit forglucosamine-chondroitin, tart cherry and omega-3 fatty acids (benefit for omega 3 fatty acids limited to patients with obesity) may help. Vitamin D is not recommended solely for AIMSS prevention or treatment. Curcumin (the active ingredient in turmeric) may have some benefit in osteoarthritis but there is a lack of data evaluating curcumin for AIMSS.
• Site-directed therapy: Carpal tunnel release, splints, or steroid injections for trigger finger may be considered when needed.
• Complementary approaches: Acupuncture, physical therapy, occupational therapy, and massage can prove beneficial.
*starting with some very low impact movement for a short period of time can help!

Let me know what has worked for you/questions!

01/23/2026

Contact your senators and ask them to support cancer research, access and funding: https://www.fightcancer.org/ or comment SENATE and I’ll send you the link in your DMs!

01/19/2026

In this video, I describe treatment options for HER2+ metastatic breast cancer. Let me know your experiences and questions!

01/18/2026

How we approach treatment for stage 1-3 HER2+ breast cancer:
-neoadjuvant (before surgery) vs adjuvant (after surgery) treatment
- neoadjuvant and adjuvant treatment regimens
-what to do for residual disease after neoadjuvant therapy

Will do a second video on HER2+ metastatic breast cancer. Let me know your questions and treatment you received if you have been diagnosed w positive .

01/17/2026

Cancer Survivorship Topics I discussed at 2026 Best of Breast Conference: menopause and hormone therapy, vaginal estrogen, hot flashes/night sweats, aromatase inhibitor musculoskeletal syndrome and sarcopenia (loss of muscle mass). In this video, I’m sharing 5 key tips/points! Let me know your questions or topics you want to hear more about.

01/17/2026

My review of PAVING Your Path Through Breast Cancer and Beyond by , .md and . An incredible resource focusing on lifestyle in breast cancer survivorship. Highly recommend!!

Comment PAVING and I’ll send you the Amazon link to the book!

01/16/2026

posted this trend so jumping on the bandwagon and putting a little twist on it.

Here’s what I say all day every day…some myth busting:

1. You can use vaginal estrogen if you have breast cancer. (Even hormone receptor positive)
2. You can eat soy if you have breast cancer.
3. You are not too young to be diagnosed w cancer (cancer is on the rise in people

01/13/2026

Highlighting 3 ongoing clinical trials of GLP-1 medications in breast and endometrial cancer.

1. FITWISE: Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/​HER2 Negative Breast Cancer
2. Tirzepatide Weight Loss for MRD+ Early Breast Cancer (TRIM-EBC)
3. A Study of a Weight Loss Intervention in People With Endometrial Cancer

Very critical research and asking the important questions. You can get more info by searching for these trials at clinicaltrials.gov as well as to get contact information, location etc if you are personally interested.

01/11/2026

New study published in JAMA Surgery (O’Reilly C et al) looking at the impact of risk reducing bilateral mastectomy (RRBM) on mortality in female carriers of the BRCA1 and BRCA2 gene variants (BRCA mutation).

Results of this study of 6135 female carriers of the BRCA1 and BRCA2 variants, demonstrated that RRBM was associated with a decrease in overall mortality and breast cancer–specific mortality, compared with not undergoing the procedure. I break down this study in the video in more detail! Let me know your questions!

Address

Luckow Pavilion One Valley Health Plaza
Paramus, NJ
07652

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+12016345578

Alerts

Be the first to know and let us send you an email when Eleonora Teplinsky, MD posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Eleonora Teplinsky, MD:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category